Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa

Clinical trials sponsored by Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa, explained in plain language.

Now part of Merck & Co., Inc. MRK NYSE

A biopharmaceutical company developing respiratory therapies, now a subsidiary of Merck.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 2

New combo inhaler aims to improve breathing in COPD patients

Disease control Ongoing

This study tests a new fixed-dose combination of two drugs (ensifentrine and glycopyrrolate) given via nebulizer twice daily for 28 days in 480 adults with COPD. The goal is to see if the combination improves lung function more than either drug alone or placebo. The trial is curr…

Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC